Is Aspire Biopharma Holdings, Inc. (ASBPW) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| DJIM | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| MSCI | 856.0% / 33% | 2.5% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| FTSE | 856.0% / 33% | 2.5% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 45.5% | |
| Operating Margin | -59015.8% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -195.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$265,186 |
| Free Cash Flow | -$265,186 |
| Total Debt | $1M |
| Current Ratio | 0.2 |
| Total Assets | $147,989 |
Price & Trading
| Last Close | $0.02 |
| Beta | 0.9 |
|
52-Week Range
$0.01
| |
About Aspire Biopharma Holdings, Inc. (ASBPW)
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Related Halal Stocks in
Frequently Asked Questions
Is Aspire Biopharma Holdings, Inc. (ASBPW) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Aspire Biopharma Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Aspire Biopharma Holdings, Inc.'s debt ratio?
Aspire Biopharma Holdings, Inc.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 856.0%.
What are Aspire Biopharma Holdings, Inc.'s key financial metrics?
Aspire Biopharma Holdings, Inc. has a market capitalization of N/A.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.